Imatinib-related bone marrow aplasia after complete cytogenetic response in chronic myeloid leukemia

被引：0
|
作者：
Khan, Khurshid Ahmed [1 ]
Junaid, Ayesha [2 ]
Siddiqui, Nauman Saleem
Mukhtar, Khalida [3 ]
Siddiqui, Saleem [3 ]
机构：
[1] Natl Oncol Res Inst, Dept Oncol, Islamabad, Pakistan
[2] Shifa Int Hosp, Dept Pathol, Islamabad, Pakistan
[3] Shifa Int Hosp, Dept Haematol & Oncol, Islamabad, Pakistan
来源：
JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN | 2008年 / 18卷 / 03期
关键词：
imatinib; chronic myeloid leukemia; bone marrow aplasia;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Imatinib mesylate is a BCR-ABL tyrosine kinase inhibitor used in the management of chronic myeloid leukemia. It is a safe and well-tolerated agent with a few manageable side effects. We are reporting a case of imatinib-related fatal bone marrow aplasia after complete cytogenetic response.
引用
收藏
页码：176 / 178
页数：3
相关论文
共 50 条
  • [31] Sustained Complete Molecular Remission after Imatinib Discontinuation in Children with Chronic Myeloid Leukemia
    Moser, Olga
    Krumbholz, Manuela
    Thiede, Christian
    Tauer, Josephine T.
    Janz, Indra
    Lauten, Melchior
    Dilloo, Dagmar
    Metzler, Markus
    Suttorp, Meinolf
    PEDIATRIC BLOOD & CANCER, 2014, 61 (11) : 2080 - 2082
  • [32] Imatinib dose reduction after major molecular response in chronic-phase chronic myeloid leukemia
    Li, Zongru
    Zhang, Xiaoshuai
    Zhao, Yijing
    Lu, Linping
    Guo, Yong
    Gale, Robert Peter
    Qin, Yazhen
    Jiang, Qian
    CANCER, 2025, 131 (01)
  • [33] CYTOGENETIC EVENTS AFTER BONE-MARROW TRANSPLANTATION FOR PHILADELPHIA-CHROMOSOME POSITIVE CHRONIC MYELOID-LEUKEMIA
    ZACCARIA, A
    ROSTI, G
    TESTONI, N
    SANTUCCI, MA
    TASSINARI, A
    CELSO, B
    BUZZI, M
    MIGGIANO, MC
    TURA, S
    LEUKEMIA RESEARCH, 1991, 15 (05) : 289 - 296
  • [34] Molecular responses of late chronic phase chronic myeloid leukemia patients after achieving complete cytogenetic responses with imatinib treatment: a 6-year follow-up
    YaZhen Qin
    Bin Jiang
    Qian Jiang
    Hao Jiang
    JinLan Li
    Yan Zhang
    HongHu Zhu
    LingDi Li
    ShanShan Chen
    YanRong Liu
    XiaoJun Huang
    Annals of Hematology, 2009, 88 : 37 - 41
  • [35] Molecular responses of late chronic phase chronic myeloid leukemia patients after achieving complete cytogenetic responses with imatinib treatment: a 6-year follow-up
    Qin, YaZhen
    Jiang, Bin
    Jiang, Qian
    Jiang, Hao
    Li, JinLan
    Zhang, Yan
    Zhu, HongHu
    Li, LingDi
    Chen, ShanShan
    Liu, YanRong
    Huang, XiaoJun
    ANNALS OF HEMATOLOGY, 2009, 88 (01) : 37 - 41
  • [36] Imatinib mesylate therapy in chronic myeloid leukemia patients in stable complete cytogenic response after interferon-alpha results in a very high complete molecular response rate
    Alimena, Giuliana
    Breccia, Massimo
    Luciano, Luigia
    Quarantelli, Fabrizio
    Diverio, Daniela
    Izzo, Barbara
    De Angelis, Biagio
    Mancini, Marco
    Latagliata, Roberto
    Carmosino, Ida
    Nanni, Mauro
    Picardi, Marco
    Rotoli, Bruno
    Mandelli, Franco
    Pane, Fabrizio
    LEUKEMIA RESEARCH, 2008, 32 (02) : 255 - 261
  • [37] Hematopoietic progenitor cell collection in patients with chronic myelogenous leukemia in complete cytogenetic remission after imatinib mesylate therapy
    Bashir, Qaiser
    De Lima, Marcos J.
    McMannis, John D.
    Garcia-Manero, Guillermo
    Shpall, Elizabeth
    Kantarjian, Hagop
    Cortes, Jorge E.
    O'Brien, Susan M.
    Jones, Dan
    Qazilbash, Muzaffar
    Wei, Wei
    Giralt, Sergio A.
    Champlin, Richard E.
    Hosing, Chitra
    LEUKEMIA & LYMPHOMA, 2010, 51 (08) : 1478 - 1484
  • [38] The Clinical Significance of Achieving Different Levels of Cytogenetic Response in Patients With Chronic Phase Chronic Myeloid Leukemia After Failure to Front-Line Therapy: Is Complete Cytogenetic Response the Only Desirable Endpoint?
    Cortes, Jorge
    Quintas-Cardama, Alfonso
    Jabbour, Elias
    O'Brien, Susan
    Verstovsek, Srdan
    Borthakur, Gautam
    Ravandi, Farhad
    Garcia-Manero, Guillermo
    Burton, Elizabeth
    Shan, Jenny
    Kantarjian, Hagop
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2011, 11 (05) : 421 - 426
  • [39] Prognostic Factors Associated with Complete Cytogenetic Response in Patients with Chronic Myelogenous Leukemia on Imatinib Mesylate Therapy
    Cojbasic, Irena
    Macukanovic-Golubovic, Lana
    SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO, 2010, 138 (5-6) : 305 - 308
  • [40] Changes in bone metabolic parameters in children with chronic myeloid leukemia on imatinib treatment
    Jaeger, Bernadette Anna Sophia
    Tauer, Josephine Tabea
    Ulmer, Anna
    Kuhlisch, Eberhard
    Roth, Heinz Juergen
    Suttorp, Meinolf
    MEDICAL SCIENCE MONITOR, 2012, 18 (12): : CR721 - CR728
12345